Vulnerability of People with Cancer and the Potential Risks of COVID-19 Pandemic: A perspective in Morocco

Cancer affects almost 18 million around the world in 2018, of these 9.5 million cases were in men and 8.5 million in women. COVID-19 is an acute respiratory disease caused by novel coronavirus SARS-CoV-2 or 2019-nCoV and was first reported in Wuhan, China in December 2019. Recently, on March 11, 2020, COVID-19 was declared by the World Health Organization (WHO) as a virus pandemic disease. Furthermore, it has been known that the malignancy and anticancer treatments, such as chemotherapy or surgery cause systemic immunosuppressive state in patients with cancer which exposes them to infection more than others especially for COVID-19 and with a high probability of complications. Additionally, the major concern for patients with cancer is the incapacity to get fundamental medical services due to the pandemic spread. In Morocco, thanks to measures such as contamination prevention, prioritization of care, and price control of therapies, cancer patients were able to continue their treatment during the covid-19 pandemic.

COVID-19, Cancer, Pandemic, Morocco

[1] Worldwide cancer data Global. Cancer statistics for the most common cancers. https://www.wcrf.org/dietandcancer/cancer-trends/worldwide-cancer-data.

[2] National Cancer Institute. Risk Factors for Cancer. https://www. cancer.gov/about-cancer/causes-prevention/risk.

[3] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, and Jemal

A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.

[4] National Cancer Institute.Cancer Treatment. https://www. cancer.gov/about-cancer/treatment.

[5] Ait Addi R, Benksim A, Amine M, Cherkaoui M. COVID-19 Outbreak and Perspective in Morocco. Electron J Gen Med. 2020;17:em204.

[6] Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19. J Med Virol. 2020;1–6.

[7] Bai Y, Yao L, Wei T, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020;323:1406-1407.

[8] Kruse RL. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan,China. 1000Res. 2020;9:72.

[9] Centers for disease control and prevention. Coronavirus Disease 2019 (COVID-19) : People Who Are At Higher Risk. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html.

[10] Lambertini M, Toss A, Passaro A, et al. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective. ESMO Open. 2020;5:e000759.

[11] Hanping Wang, Li Zhang. Risk of COVID-19 for patients with cancer. Lancet oncol. 2020;21:E181.

[12] Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335-337.

[13] Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol. 2020;31:553‐555.

[14] Rivera A, Ohri N, Thomas E, Miller R, Knoll MA. The Impact of COVID-19 on Radiation Oncology Clinics and Cancer Patients in the U.S. Adv Radiat Oncol. 2020. doi:10.1016/j.adro.2020.03.006.

[15] Yuen E, Fote G, Horwich P, et al. Head and neck cancer care in the COVID-19 pandemic: A brief update. Oral Oncol. 2020;105:104738.

[16] Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global. Nat Rev Clin Oncol. 2020;17:268-270.

[17] Lu H, Zhao B, Zhang J, et al. Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis [published online ahead of print, 2020 Jan 8]. Eur J Surg Oncol. 2020;S0748-7983:30017-2.

[18] Covid-19/Maroc : Ne pas oublier les patients atteints de cancer du poumon. https://fr.hespress.com/142811-covid-19-maroc-ne-pas-oublier-les-patients-\atteints-de-cancer-du-poumon.html.